{"mainPropery":{"diseaseId":7183,"diseaseName":"Sialidosis, type II","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7183/sialidosis-type-ii","synonyms":["Mucolipidosis type 1","Neuraminidase deficiency","Lipomucopolysaccharidosis","Sialidase deficiency","Glycoprotein neuraminidase deficiency","ML1","NEUG deficiency","Neuraminidase 1 deficiency","NEU 1 deficiency"],"synonyms-with-source":[{"name":"Mucolipidosis type 1"},{"name":"Neuraminidase deficiency"},{"name":"Lipomucopolysaccharidosis"},{"name":"Sialidase deficiency"},{"name":"Glycoprotein neuraminidase deficiency"},{"name":"ML1"},{"name":"NEUG deficiency"},{"name":"Neuraminidase 1 deficiency"},{"name":"NEU 1 deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"256550"},{"identifierType":"ORPHANET","identifierId":"87876"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases"}],"organizations":[{"resourceID":37,"resourceName":"Canadian Society for Mucopolysaccharide and Related Diseases Inc. (Canadian MPS Society)","abbreviation":"","address1":"#218-2055 Commercial Drive ","address2":"Vancouver, BC V5N OC7","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"604-924-5130","tty":"","tollFree":"800-667-1846","fax":"604-924-5131","email":"info@mpssociety.ca","url":"http://www.mpssociety.ca","freeText":""},{"resourceID":209,"resourceName":"National MPS Society","abbreviation":"","address1":"P.O. Box 14686 ","address2":"","address3":"","address4":"","address5":"","city":"Durham","state":"NC","zip":"27709-4686","country":"United States","phone":"+1-919-806-0101","tty":"","tollFree":"1-877-MPS-1001 (1-877-677-1001)","fax":"+1-919-806-2055","email":"info@mpssociety.org","url":"https://mpssociety.org/","freeText":""},{"resourceID":210,"resourceName":"Society for Mucopolysaccharide (MPS) Diseases","abbreviation":"","address1":"MPS House Repton Place White Lion Road","address2":"Amersham Buckinghamshire","address3":"HP7 9LP","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"(+44) 0345 389 9901 ","tty":"","tollFree":"","fax":"","email":"mps@mpssociety.co.uk","url":"http://www.mpssociety.co.uk","freeText":""},{"resourceID":318,"resourceName":"Hide and Seek Foundation for Lysosomal Storage Disease Research","abbreviation":"","address1":"6475 East Pacific Coast Highway","address2":"Suite 466","address3":"","address4":"","address5":"","city":"Long Beach","state":"CA","zip":"90803 ","country":"United States","phone":"","tty":"","tollFree":"(844) 762-7672","fax":"","email":"info@hideandseek.org","url":"https://hideandseek.org","freeText":""},{"resourceID":748,"resourceName":"The International Advocates for Glycoprotein Storage Diseases (ISMRD)","abbreviation":"","address1":"20880 Canyon View Drive","address2":"","address3":"","address4":"","address5":"","city":"Saratoga","state":"CA","zip":"95070","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"info@ismrd.org","url":"https://www.ismrd.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/256550' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=sialidosis%20type%202%5Bti%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Sialidosis, type II. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/sialidosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Sialidosis, type II. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":282,"resourceId":748,"resourceName":"The International Advocates for Glycoprotein Storage Diseases (ISMRD)","descriptionText":"<a href='http://www.ismrd.org/5th_family_workshop/overview ' target='_blank'>2012 International Conference for Glycoprotein Storage Diseases</a>, July 27, 2012 - July 30, 2012<br /><strong>Location</strong>: Crowne Plaza Hotel, Charleston, SC<br /><strong>Description</strong>: The International Society for Mannosidosis &amp; Related Storage Diseases (ISMRD) is sponsoring the 2012 International Conference for Glycoprotein Storage Diseases. The Scientific/Family meetings will be held concurrently on July 28th and 29th. Alongside this meeting, they are hosting the extension of the Natural History Study, with clinic days on July 27th and 30th.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0268226' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/302/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/mucolipidoses/detail_mucolipidoses.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/948704-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=87876' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:256550' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3784,"questionText":"What is sialidosis type II?","answerText":"Sialidosis is a severe inherited disorder that affects many organs and tissues, including the nervous system. This disorder is divided into two types, which are distinguished by the age at which symptoms appear and the severity of features. <strong>Sialidosis type II</strong>, the more severe type of the disorder, is further divided into congenital, infantile, and juvenile forms.[2673]&nbsp;This type of sialidosis&nbsp;often begins during infancy or later during childhood and is characterized by cherry-red macules, mildly coarse facial features, skeletal malformations and mild cognitive impairment.[2674] Sialidosis type II is caused by mutations in the <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NEU1\" target=\"_blank\">NEU1</a></em></span> gene. People with sialidosis type II have mutations that severely reduce or eliminate NEU1 enzyme activity. The condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.[2673]","dateModified":"2015-08-13T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9367,"phenoTypeName":"Abnormal macular morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4096,"phenoTypeName":"Ascites","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9878,"phenoTypeName":"Coarse facial features","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14402,"phenoTypeName":"Corneal opacity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14142,"phenoTypeName":"Delayed speech and language development","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10270,"phenoTypeName":"Dysostosis multiplex","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3910,"phenoTypeName":"Hydrops fetalis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6359,"phenoTypeName":"Inguinal hernia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":7902,"phenoTypeName":"Kyphosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10043,"phenoTypeName":"Nephropathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12819,"phenoTypeName":"Pedal edema","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13169,"phenoTypeName":"Short thorax","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4092,"phenoTypeName":"Umbilical hernia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10268,"phenoTypeName":"Osteoporosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14140,"phenoTypeName":"Pectus carinatum","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9592,"phenoTypeName":"Abnormality of bone marrow cell morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4768,"phenoTypeName":"Dysphonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13726,"phenoTypeName":"Dyspnea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5672,"phenoTypeName":"Flexion contracture","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":3616,"phenoTypeName":"Bone-marrow foam cells","percentRanges":"-"},{"phenoTypeId":8971,"phenoTypeName":"Cardiomegaly","percentRanges":"-"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","percentRanges":"-"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","percentRanges":"-"},{"phenoTypeId":12809,"phenoTypeName":"Cherry red spot of the macula","percentRanges":"-"},{"phenoTypeId":9396,"phenoTypeName":"Dysmetria","percentRanges":"-"},{"phenoTypeId":2795,"phenoTypeName":"Epiphyseal stippling","percentRanges":"-"},{"phenoTypeId":9873,"phenoTypeName":"Facial edema","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":13579,"phenoTypeName":"Increased urinary O-linked sialopeptides","percentRanges":"-"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","percentRanges":"-"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","percentRanges":"-"},{"phenoTypeId":5641,"phenoTypeName":"Progressive visual loss","percentRanges":"-"},{"phenoTypeId":10031,"phenoTypeName":"Proteinuria","percentRanges":"-"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","percentRanges":"-"},{"phenoTypeId":5658,"phenoTypeName":"Slurred speech","percentRanges":"-"},{"phenoTypeId":1695,"phenoTypeName":"Urinary excretion of sialylated oligosaccharides","percentRanges":"-"},{"phenoTypeId":15556,"phenoTypeName":"Vacuolated lymphocytes","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Sialidosis,_type_II"}